Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma Interventions: Drug: Idarubicin Hydrochloride for Injection; Drug: Epirubicin Sponsor: Zhejiang Cancer Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Hospitals | Liver Cancer | Research